Literature DB >> 9366923

Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression.

R D Guttmann1, P Caudrelier, G Alberici, J L Touraine.   

Abstract

The pharmacokinetics and immune response to the rabbit IgG of rabbit antihuman thymocyte globulin, Thymoglobuline has been characterized. A cytokine release pattern of TNF alpha and IL-6 but not IL-1 beta and IFN chi has been demonstrated with the first and not subsequent doses. An effect on lymphocyte depletion of peripheral blood with major subset suppression has been shown to last more than the 3-month observation period in patients on a regimen of quadruple sequential immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366923

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  13 in total

Review 1.  Overview of immunosuppression in liver transplantation.

Authors:  Anjana A Pillai; Josh Levitsky
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

2.  First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection.

Authors:  S M Flechner; S Mulgoankar; L B Melton; T H Waid; A Agarwal; S D Miller; F Fokta; M T Getts; T J Frederick; J J Herrman; J P Puisis; L O'Toole; R Sung; F Shihab; A C Wiseman; D R Getts
Journal:  Am J Transplant       Date:  2014-04-17       Impact factor: 8.086

Review 3.  Current status of immunosuppression in liver transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rajat Shukla; Hardik Kotecha; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2013-06-03

4.  Administration of anti-thymocyte globulin: a comparison of two protocols.

Authors:  A B Clemmons; M E Hartranft; V Kota; J Pantin; F T Awan; H Salman; A P Jillella
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

5.  Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.

Authors:  M Hummel; Z Zhang; S Yan; I DePlaen; P Golia; T Varghese; G Thomas; M I Abecassis
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.

Authors:  Xingmin Feng; Phillip Scheinberg; Angelique Biancotto; Olga Rios; Sarah Donaldson; Colin Wu; Haiyun Zheng; Kazuya Sato; Danielle M Townsley; J Philip McCoy; Neal S Young
Journal:  Haematologica       Date:  2014-06-06       Impact factor: 9.941

7.  Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review.

Authors:  John T Denny; Andrew T Burr; Fred Balzer; James T Tse; Julia E Denny; Darrick Chyu
Journal:  Exp Ther Med       Date:  2015-03-12       Impact factor: 2.447

8.  Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.

Authors:  Diana Stauch; Annelie Dernier; Elizabeth Sarmiento Marchese; Kristina Kunert; Hans-Dieter Volk; Johann Pratschke; Katja Kotsch
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

Review 9.  Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.

Authors:  Emma D Deeks; Gillian M Keating
Journal:  Drugs       Date:  2009-07-30       Impact factor: 9.546

10.  Idiopathic intracranial hypertension immediately after kidney transplantation in a pediatric recipient.

Authors:  Sookkasem Khositseth; Blanche M Chavers; Desiree Czapansky-Beilman; Michael Mauer
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.